These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 17239332

  • 1. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
    Schémann JF, Guinot C, Traore L, Zefack G, Dembele M, Diallo I, Traore A, Vinard P, Malvy D.
    Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB, House J, Hong KC, Lakew T, Alemayehu W, Zhou Z, Moncada J, Rogér A, Keenan J, Gaynor BD, Schachter J, Lietman TM.
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
    Stare D, Harding-Esch E, Munoz B, Bailey R, Mabey D, Holland M, Gaydos C, West S.
    Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
    [Abstract] [Full Text] [Related]

  • 6. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
    Bowman RJ, Sillah A, Van Dehn C, Goode VM, Muqit MM, Johnson GJ, Milligan P, Rowley J, Faal H, Bailey RL.
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
    [Abstract] [Full Text] [Related]

  • 7. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM, Jha HC, Lietman TM, Chaudhary JS, Bhatta RC, Elliott J, Hyde T, Schuchat A, Gaynor B, Dowell SF.
    Clin Infect Dis; 2002 Aug 15; 35(4):395-402. PubMed ID: 12145722
    [Abstract] [Full Text] [Related]

  • 8. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.
    Broman AT, Shum K, Munoz B, Duncan DD, West SK.
    Invest Ophthalmol Vis Sci; 2006 Jan 15; 47(1):99-104. PubMed ID: 16384950
    [Abstract] [Full Text] [Related]

  • 9. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?
    Bird M, Dawson CR, Schachter JS, Miao Y, Shama A, Osman A, Bassem A, Lietman TM.
    J Infect Dis; 2003 May 15; 187(10):1669-73. PubMed ID: 12721948
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Strategies to control trachoma].
    Schémann JF, Sacko D.
    Sante; 1998 May 15; 8(2):150-6. PubMed ID: 9642742
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children.
    Frick KD, Lietman TM, Holm SO, Jha HC, Chaudhary JS, Bhatta RC.
    Bull World Health Organ; 2001 May 15; 79(3):201-7. PubMed ID: 11285663
    [Abstract] [Full Text] [Related]

  • 17. Global elimination of trachoma: how frequently should we administer mass chemotherapy?
    Lietman T, Porco T, Dawson C, Blower S.
    Nat Med; 1999 May 15; 5(5):572-6. PubMed ID: 10229236
    [Abstract] [Full Text] [Related]

  • 18. Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana.
    Solomon AW, Akudibillah J, Abugri P, Hagan M, Foster A, Bailey RL, Mabey DC.
    Bull World Health Organ; 2001 May 15; 79(1):8-14. PubMed ID: 11217675
    [Abstract] [Full Text] [Related]

  • 19. Outcome of azithromycin treatment of active trachoma in Omani school children.
    Khandekarf R, Mohammed AJ.
    East Mediterr Health J; 2003 May 15; 9(5-6):1026-33. PubMed ID: 16450533
    [Abstract] [Full Text] [Related]

  • 20. Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children.
    Coles CL, Levens J, Seidman JC, Mkocha H, Munoz B, West S.
    Pediatr Infect Dis J; 2012 Apr 15; 31(4):341-6. PubMed ID: 22173140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.